INTERSTATE AND FOREIGN COMMERCE
HOUSE OF REPRESENTATIVES

NINETY-SECOND CONGRESS

COMMITTEE ON INTERSTATE AND FOREIGN COMMERCE

HARLEY O. STAGGERS, West Virginia, Chairman

TORBERT H. MACDONALD, Massachusetts

Ambrose, Myles J., Special Assistant Attorney General, Director,
Office for Drug Abuse Law Enforcement, Department of Justice__
Broderick, Matthew, counsel, Pennwalt Corp--

218

188

Chayet, Neil L., counsel, Committee for Effective Drug Abuse Legis-

lation__

111

Durrin, Kenneth, Assistant Director, Bureau of Narcotics and Dan-

gerous Drugs, Department of Justice..

241

131

Edwards, Dr. Charles C., Commissioner, Food and Drug Administra-

tion, Department of Health, Education, and Welfare.

Gardner, Dr. Elmer, Director, Division of Neuropharmacological Drug

Products, Food and Drug Administration, Department of Health,

Education, and Welfare..

Gurowitz, Edward M., Ph. D., director of clinical services, town of

Huntington (N. Y.) Narcotic Guidance Council.

Head, Dr. William F., vice president, technical operations, Pharma-

ceutical Division, Pennwalt Corp., in behalf of the Strasenburgh

Prescription Products Division of Pennwalt Corp---

Hutt, Peter Barton, Assistant General Counsel, Food and Drug

Administration, Department of Health, Education, and Welfare.-

Ingersoll, John E., Director, Bureau of Narcotics and Dangerous

Drugs, Department of Justice_

Lewis, Dr. Edward, Chief Medical Officer, Bureau of Narcotics and

Dangerous Drugs, Department of Justice.

Miller, Donald, Chief Counsel, Bureau of Narcotics and Dangerous

Drugs, Department of Justice...

131

182

188

131

2, 241

2 2

Perito, Paul L., Deputy Director, Special Action Office for Drug

Abuse Prevention, Executive Office of the President_

218

Rosthal, Robert, Deputy Chief Counsel, Bureau of Narcotics and

Dangerous Drugs, Department of Justice_-_

241

Schmitz, Hon. John G., a Representative in Congress from the State
of California__

215

Scoville, Dr. Barrett, Deputy Director, Division of Neuropharma-

cological Drug Products, Food and Drug Administration, Depart-

ment of Health, Education, and Welfare-

131

Additional material submitted for the record by-

Committee for Effective Drug Abuse Legislation:

Editorial from the New England Journal of Medicine, entitled

"Legislative Harassment of Physicians and Researchers"-

Form for application for registration under Controlled Substances

Act of 1970........

125

117

How researchers obtain schedule I controlled substances-
schematic...

119

Telegram dated January 24, 1972, from Neil L. Chayet, counsel,
Committee for Effective Drug Abuse Legislation, and others,
to President Richard M. Nixon re protest against current regu-
lations promulgated by BNDD...

(HD)

124